CC BY
12
УДК 616.832-006:616.832-089
J.D. Banjarnahor1,2, R.H. Dahlan1,2,3, S.E. Ompusunggu1,2,3
1 Hasan Sadikin General Hospital, Bandung, Indonesia
2 Universitas Padjadjaran, Bandung, Indonesia
3 RFS Spine Care, Bandung, Indonesia
THE EFFECT OF TIME INTERVAL TO SURGERY ON THE CLINICAL OUTCOME OF PATIENTS WITH INTRAMEDULLARY TUMOR AT HASAN SADIKIN GENERAL
HOSPITAL
Objective: the authors analysed the outcome of intramedullary spinal cord tumor surgery, focusing on the preoperative & postoperative neurological status and influence of time interval on clinical outcome of surgery. Methods: retrospective analysis of medical records of 25 intramedullary tumour patients, operated at our institute between Jan 2012 - Jan 2018 was done. Pre - and postoperative neurological status was determined. Ambulatory status were evaluated using the modified McCormick Scale (MMS).
Results: 44% of the patients were in 41-60years of age group (age range, 18-80years; mean age 37 years). Region most commonly affected was thoracic (48%). The preoperative McCormick grade was I in 0 (0%), II in 2 (8%), III in 6 (24%), IV in 10 (40%), and V in 7 (28%) patients. Histologically 60% of the lesions were ependymomas. Overall postoperative neurological status improved in 8 (32%) of the patients, remained unchanged in 27 (68%) of cases, and deteriorated in 0 (0%) patients.
Conclusion: better outcome correlated with good preoperative Modified McCormick Scale. Time interval for surgery does not significantly affected clinical outcome. We favor early preoperative Modified McCormick Scale as a stronger indicator to predict outcome and time to do optimal resection in IMSCTpatients. Keywords: intramedullary spinal cord tumor, Time interval, Modified McCormick Scale.
Introduction
Intramedullary Spinal Cord Tumor/IMSCT is a rare malignancy of the central nervous system (CNS), with prevalence rate at 2-4% of the overall neoplasm of CNS, and 15-20% of all spine malignancies [1-6]. In majority of the cases, eppendymoma identified as the etiology, followed by astrocytoma and other neoplasm types, such as hemangioblastoma, gan-glioglioma, germinoma, primary CNS lymphoma and melanoma [4, 7, 8]. Thus we can conclude that the majority of IMSCT are benign and originated from glial cells, neurons or cells of connective tissue. According to their cells of origin, these glial cell tumors can be diagnosed with astrocytoma, eppendymoma, and oligodendroglioma [5, 8]. Of these three types, astrocytoma is a neoplasm that is originated from astrocytes of the spinal cord, hence tumor resection can become a technical challenge [2, 6]. Additionally, despite its less prevalence, IMSCT can also be the product of distant metastasis of other types of tumor elsewhere [1, 4].
Due to its anatomical nature, IMSCT is a malignancy that can potentially cause severe neurological
impairment, disabilities, leading to low quality of life and painful death. At the onset of the disease, the most common symptom identified in patients with IMSCT is backpain, including diffuse and/or radicular pain. Moreover, IMSCT can also cause motoric and sensoric functions, such as paresthesia, spasticity, or even muscle weakness. In some cases, contractility of visceral organs are also severely impaired, leading to inability to urinate and defecate. Thus, mortality seemed inevitable unless treatment is correctly planned and executed [1, 2, 3, 6, 7].
To date, confirmation of the diagnosis of this tumor type can only be obtained with histopathol-ogy examination. Concordantly, microsurgery is the preferred therapy to optimise tumor resection [6, 9, 10]. Despite progress in certain aspects, treatment of intramedullary tumor remained clinically challenging for spine practitioners as the available choices of treatment are very limited. Thus, a concensus on the standardized treatment for intramedullary tumor are yet to be achieved [1, 2, 7].
Nevertheless, some authors have proposed strategies to be adapted as a standard treatment for intra-
Rully Hanafi Dahlan, email: [email protected]
HEI/IPOXI/IPyPR/m I/I HEBPO-HOR/m KA3AXCTAHA №1 (54) 2019
medullary tumors. Despite existing disagreements, all agreed that in order to obtain optimum post-operative functional results, an early diagnosis and treatment, including tumor resection, is key [2, 5, 7]. Ideally, tumor ressection of this tumor type should always be concluded in a total removal of the tumor tissue, hence possibility for future recurences can be minimized and long term survival rates can be expected. Unfortunately, this has not always been doable [1-7].
One way to increase the possibility to be able to remove the tumor tissue totally is to confirm the diagnosis as early as possible [1, 8]. Moreover, some authors have also suggested that interval of surgery, pre-operative and post-operative neurological state, tumor location, histopathological analysis and patients' quality of life contribute significantly to tumor recurrences and overall outcomes [9, 11].
Despite it has been hypothesized that the time interval to surgery is an important factor that affects the overall outcome of treatment, only a few of the data have been published [9, 12]. Kane et al. concluded that Gait abnormality was only found worsen in 6 of 54 cases (12%) [13]. Some authors believe that intramedullary tumor resection has to be performed as soon as Gait abnormality is identified, without waiting for any further worsening of the symptom itself.
In this study, the authors aim to investigate the effect of the time interval to surgery on the outcome. Hence, Modified McCormick Scale was used as a parameter to assess spinal cord functionalities. Results from functional assessment during preoperative period were then compared with the results of the portoperative period in every patient. Final results were classified into 3 different subgroups: "Improved", "Unchanged" and "Worsen". RESULTS
Patients' Characteristics Initially, this study included 28 intramedullary tumor patients from 2012-2017 in department of Neurosurgery at Hasan Sadikin Hospital. Among these 28 patients, 3 patients were excluded from the study, including 1 patient who died at the hospital, and 2 patients who requested a forced discharge before further examinations. The patients approved written informed consent before the inclusion in this study.
Of 25 patients who were included in this study, 13 patients (52%) are male, and 12 patients (48%) are women, suggesting gender differences is not existing in this study. (Table 1). Patients' age were vary between 18-84 year-old, while the mean age is 37.32-year-old. The majority of patients (11 patients) were aged between 41-60 years (44%), while the minority (2 patients) aged>60-year-old (8%).
Table 1
PATIENTS' GENDER DISTRIBUTION IN THIS STUDY, INCLUDING 13 PATIENTS ARE MALE, WHILE 12
PATIENTS ARE FEMALE.
Sex Male 13 52 %
Female 12 48 %
Age 18 - 20 4 16 %
21 - 40 8 32 %
41 - 60 11 44 %
> 60 2 8 %
Tumor Location Cervical 11 44 %
Thoracal 12 48 %
Lumbal & Conus 2 8 %
Location of Tumors
Results from MRI examination acknowledged that the majority of intramedullary tumor was located in thoracic vertebra (12 patients ~ 48%) and cervical (11 patients ~ 44%), suggesting that there is no significant difference on the predilection of tumor in these 2 regions. Of all, only 2 patients had tumor at lumbal and conus (8%).
Time Interval to Surgery, Intraoperative Findings and Examination Results
Of 25 intramedullary tumor patients who were included in this study, more than 50% were operated in more than 12 months after having onset of symptoms, and only 2 patients had their surgery in the duration of 1-3 months after onset of symptoms. The mean time interval to surgery is 16.68 months after the onset of symptoms was identified (Figure 1).
Figure 1 - Most patients who were diagnosed with IMSCT had surgery>12 months after the onset of symptom(s)
Pre-Operative and Post-Operative Modified McCormick Scale in IMSCT Patients
Results of this study showed that most of our IMSCT patients (n=10) had preoperative Modified McCormick Scale of IV, indicating that most patients were presented with a severe deficit of motoric and/or sensoric functions, thus needing other people's assistances. As many of 7 patients (28%) were presented with preoperative Modified McCormick Scale of V, suggesting that they were presented with tetraplegic or paraplegic. Conversely, there were only 2 of our patients (8%) who came with mild neurological deficit (Figure 2).
Figure 2 - Majority of IMSCT patients had preoperative Modified McCormick Scale of IV
Post-operative examinations revealed that the majority of patients (n=9) had post-operative modified McCormick scale of IV, indicating that severe sensoric and motoric deficit persisted, thus patients remained dependent of caregivers. Furthermore, 7 patients (~28%) remained tetraplegic or paraplegic. Only 5 patients (20%) had post-operative modified McCormick scale of II, and the other 4 patiens (16%) were identified for having modified McCormick scale III (Figure 3).
Figure 3 - Post-operative Modified McCormick scale in IMSCT patients showed that the majority of patients had the scale of IV, while the rest of the patients had varies scale of III, II and IV, respectively. No patients that were operated at Hasan Sadikin had scale of I
Histopathology Analyses of the Tumor
Based on histopathology analyses of the tumor tissue that were collected during the tumor removal surgery at Hasan Sadikin General Hospital, the majority of IMSCT specimens were identified as ependymoma (n=15, ~60%), followed by astrocytoma (n=7, ~28%) and varies of other IMSCT tumor types, such as cavernous angioma (n=1, ~4%) and arachnoid cyst (n=1, ~4%) (Figure 4).
Results of Histopathological Examinations in IMSCT Patients
is
14 12 10
5
6 4 2 0
7
I
1 ] 1
Ependymoma Astrocytoma Cavernous Angioma Lymphoma Arachnoid Cyst ■ Histopathology
Figure 4 - Histopathology examinations of IMSCT patients' tummor tissue revealed ependymoma as the tumor type in majority of patients, followed by astrocytoma, cavernous angioma, lymphoma and arachnoid cyst
Improvement of Modified McCormick Scale in IMSCT Patients at Post-operative Period
To assess the impact of tumor removal on IMSCT patients' Modified McCormick Scale, we compare pre-operative Modified McCormick Scale with post-operative Modified McCormick Scale in every patient. As expected, as many as 8 patients experienced an increase of modified McCormick scale at post-operative period. Of these 8 patients, 7 patients (~87,5%) had timeinterval to surgery of less than 12
26—
НЕЙРОХИРУРГИЯ И НЕВРОЛОГИЯ КАЗАХСТАНА
№1 (54) 2019
months. The majority of patients (6 patients ~75%) McCormick scale of III and IV. The results of this study who showed an mprovement of Postoperative mod- also showed that the number of improvement in ified McCormick scale had a pre-operative modified these patients are limited to 1 scale.
Table 2
Table of Bivariate Analysis shows proportion and correlation between pre-operative and post-operative modified McCormick scale in IMSCT patients
BIVARIATE ANALYSIS OF PRE-OPERATIVE MODIFIED MCCORMICK SCALE AND POST-OPERATIVE MODIFIED MCCORMICK SCALE
Pre-operative Modified McCormick Post-operative Modified McCormick Scale Correlation (r) P Value
Scale I I I I I I IV V
I I I 0,766 0,000 *
II 2
III 3 3
IV 3 7
V I I 2 5
Total 5 6 9 5
As shown on table 2, patients with pre-operative modified McCormick scale of II had no change of post-operative modified McCormick scale, while only 2 out of 7 patients who were admitted with pre-oper-ative modified McCormick scale of V had an increase of 1 scale when examined at post-operative period.
None of the patients had an increase of more than 1 scale. As such, statistical analysis using Pearson's Chi-Square test showed that the correlation between pre-operative and post-operative modified McCormick scale is statistically significant (p value<0,05).
Table 3
Bivariate analysis on time interval to surgery and post-operative modified McCormick scale in IMSCT patients
CORRELATION BETWEEN TIME INTERVAL TO SURGERY AND POST-OPERATIVE MODIFIED MCCORMICK SCALE
Time interval Post-operative Modified Correlation P Value
to surgery McCormick Scale (n patients) (r)
(months) I I I I I I IV V
<1 month 0,600 0,298
1 - 3 months 1 1 1
3 - 6 months 1 1
6 - 9 months 2 2 1 1
9 - 12 months 2
>12 months 5 2 6 4
Table 3 shows that despite the data suggests there may be some correlations between time interval to surgery and post-operative modified McCormick scale, the p value suggests that any possible correlations are statistically insignificant (p value>0,05).
Nonetheless, the data shows that patients with time interval to surgery of>12 months are more likely to acquire unfavorable post-operative outcomes showed by modified McCormick scale of IV and V (10 patients ~ 40%).
Table 4
Bivariate analysis on tumor histopathology and post-operative modified McCormick scale in IMSCT patients
CORRELATION BETWEEN TUMOR HISTOPATHOLOGY WITH POSTOPERATIVE MODIFIED MCCORMICK SCALE
Tumor Postoperative Number Correlation P Value
Histopathology Modified of (r)
McCormick Scale Patients
I I I I I I IV V
Ependymoma 3 3 7 2 15 0,615 0,230
Astrocytoma 1 3 3 7
Cavernous Angioma 1 1
Lymphoma 1 1
Arachnoid Cyst 1 1
Total 5 6 9 5 25
Even though the data shows that the effect of tumor histopathology on post-operative modified McCormick scale is insignificant, the r value suggests that tumor histopathology and post-operative modified McCormick scale is strongly correlated (r=0,615). This data acknowledges that patients who were di-ganosed with astrocytoma acquire more unfavorable post-operative modified McCormick scale of IV and V (n=9 ~ 60%). Discussion
Intramedullary Spinal Cord Tumor (IMSCT) is a rare yet fatal neoplasm of the spinal cord that is mainly diagnosed in productive patients. Due to its location, this tumor type leads to disabilities in its patients, thus severely impaired their quality of lives.
As expected, the longer the time interval to surgery is, the more unfavorable the outcome in patients after surgery will be. As shown on table 3, 10 patients who underwent surgery in>12 months after the onset of symptoms acquired post-operative modified McCormick scale of IV and V. Nonetheless, to our surprise, the effect of time interval to surgery on the outcome of patient's treatment is not statisti-
Although progress in neurosurgical operative techniques have better equipped neurosurgeon when treating patients with IMSCT, overall outcomes remain far from ideal, therefore further understanding in disease pathogenesis and treatment, including patient's characteristics may offer valuable insights to further optimize the treatment of IMSCT patients.
In this study, we evaluated the effect of time interval to surgery on the IMSCT patients' treatment outcome. To do so, we used pre-operative and post-operative modified McCormick scale (MMS) as the standardized description of patient's condition. MMS is a parameter that can be used to evaluate the functionalities of spinal cord, therefore can be applied as an overview of the quality of life in patients who are diagnosed with IMSCT.
cally significant. Likewise, despite the possible effect of tumor histopathology on patient's outcome, such correlation is also statistically insignificant.
Interestingly, bivariate analysis of pre-operative and post-operative modified McCormick scale showed that these 2 parameters are significantly correlated, suggesting that the pre-operative neurological conditions in IMSCT patients affect post-operative outcomes. As
Table 5
Evaluation of spinal cord function with Modified McCormick Scale 9
Grade Explanation
I Neurologically intact, ambulates normally, may have minimal dysesthesia
II Mild motor or sensory deficit; patient maintains functional independence
III Moderate deficit, limitation of function, independent with external aid
IV Severe motor or sensory deficit, limit of function with a dependent patient
V Paraplegic or quadriplegic, even if there is flickering movement
28 ^ HEI/IPOXI/IPyPn/m I/I HEBPO-HOni/m KA3AXCTAHA №1 (54) 2019
shown on table 2, although patients with pre-operative MMS of II did not acquire any improvement of neurological functions after surgery, patients with preoperative MMS of > III have higher possibilities to acquire improvement of neurological functions when they underwent operation with better pre-operative MMS.
To our knowledge, evaluation of neurological functions with MMS is influenced by several factors, such
as duration of disease, tumor location, tumor malignancy and tumor type. Based on this, we can conclude that the insignificance effect of tumor location, time interval to surgery and tumor histopathology is mainly due to sample size. Hence, we recommend future studies would include larger sample size.
REFERENCES
1. Tobin M.K., Geraghty J.R., Engelhard H.H., Linninger A.A., Mehta A.I. Intramedullary spinal cord tumors: a review of current and future treatment strategies // Neurosurg Focus. - 2015. - 39(2). -P. E14.
2. Boström A., Kanther N-C., Grote A., Boström J. Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience // BMC Research Notes. -2014. - 7. - P. 908. doi:10.1186/1756-0500-7-908.
3. Bellut D., Burkhardt J.K., Mannion A.F., Porchet F. Assessment of outcome in patients undergoing surgery for intradural spinal tumor using multidimensional patient-rated Core Outcome Measure Index and the modified McCormick Scale // Neurosurg Focus. - 2015. - 39(2). - P. E2.
4. Manzano G., Green B.A., Vanni S., Levi A.D. Contemporary management of adult intramedul-lary spinal tumors-pathology and neurological outcomes related to surgical resection // Spinal Cord. - 2008. - 46(8). - P. 540-6.
5. Choi I., Hyun S., Kang J., Rhim S. Combined muscle motor and somatosensory evoked potentials for intramedullary spinal cord surgery // Yonsei Med J. - 2014. - 55(4). - P. 1063-1071.
6. Malhotra N.R., Bhowmick D., Hardesty D., Whitfield P. Intramedullary spinal cord tumours: diagnosis, treatment, and outcomes // ACNR. -2010. - 10(4). - P. 21-26.
7. Garcés-Ambrossi G.L., McGirt M.J., Mehta V.A., Sciubba D.M., Witham T.F., et al. Factors asso-
ciated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases // J Neurosurg Spine. -2009. - 11(5). - P. 591-9.
8. Samartzis D., Gillis C.C., Shih P., O'Toole J.E., Fessler R.G. Intramedullary Spinal Cord Tumors: Part I—Epidemiology, Pathophysiology, and Diagnosis // Global Spine Journal. - 2015. - 5(5). -P. 425-435.
9. Taricco M.A., Guirado V.M., Fontes R.B., Plese J.P Surgical treatment of primary intramedullary spinal cord tuors in adult patients // Arq Neu-ropsiquiatr. - 2008. - 66 (1). - P. 59-63.
10. Raj V.S., Lofton L.T. Invited review: rehabilitation and treatment of spinal cord tumors // The Journal of Spinal Cord Medicine. - 2013. - 36(1). - P. 1-8.
11. Chamberlain M.C., Tredway T.L. Adult primary intradural spinal cord tumors: a review // Curr Neurol Neurosci. - 2011. - 11(2). - P. 320-8.
12. Jaiswal M., Mittal R.S. Outcome of operative intervention in intramedullary spinal cord tumours // Romanian Neurosurgery. - 2014. - XXI (3). - P 283-291.
13. Kane P.J., el-Mahdy W., Singh A., Powell M.P., Crockard H.A. Spinalintradural tumours: Part II— Intramedullary // Br J Neurosurg. - 1999. - 13. -P. 558-563.
Banjarnahor1,2, R.H. Dahlan1,2,3, S.E. Ompusunggu1,2,3
1 Х. Садикин атындагы жалпы аурухана, Бандунг к., Индонезия
2 Паджаджаран университету Бандунг к., Индонезия
3 RFS Spine Care, Бандунг к., Индонезия
ХАСАН САДИКИН АТЫНДАГЫ ЖАЛПЫ АУРУХАНАДА ИНТРАМЕДУЛЯРЛЫ 1С1КТЕР1 БАР НАУКАСТАРГА ЖАСАЛГАН ОПЕРАЦИЯЛАРДЬЩ КЛИНИКАЛЫК, НЭТИЖЕС1НЕ УАКЫТ АРАЛЫГЫНЫЦ ЫК.ПАЛЫ
Мацсаты: ОперацияFа дейiнгi жэне опера-циядан кейiнгi неврологиялык жаFдаЙFа жэне операциянык клиникалык нэтижесiне уакыт ара-лы^ынык эсер eTyiHe назар аудара отырып, интра-медулярлы жулын iciri операциялары (IMSCT) Yшiн хирургиянык нэтижeлeрi талданды.
М1ндеттер1: 2012 жылдык кактар айынан бастап 2018 жылдык кактарына дeйiн жаткы-зылFан интрамедулярлы iciri бар 25 наукастык медициналык eceптeрiнe рeтроcпeктивтi талдау жасалды. ОпeрацияFа дeйiнгi жэне операциядан кeйiнгi неврологиялык жаFдаЙFа баFалаy жYргiзiл-дi. Амбулаториялык жаFдай McCormick модифика-цияланFан шкаласы (MMS) аркылы баFаланды.
Нэтижелерк наукастардык 44% -ы 41-60 ара-лыFындаFы (жалпы жас аралыFы 18-80, орташа -37 жас) жас тобында болFан. Квбiнe кеуде аймаFы зардап шеккен (48%). ОпeрацияFа дeйiнгi кезекде пациенттер McCormick шкаласы бойынша твмен-дeгiдeй Yлecтiрiлдi: I декгейде 0 (0%), II-де 2 (8%),
11-де 6 (24%), IV-де 10 (40%) жэне V-де 7 (28%). Гистологиялык т^ыдан алFанда, закымданулар-дык 60% эпендимома болды. Жалпы 8 (32%) на-укаста жалпы операциядан кейшп неврологиялык жаFдай жаксарды, 27 (68%) жаFдайда взгeрicciз калды жэне 0 (0%) наукаста нашарлады.
Цорытынды: Операциядан кейнп жаксы-рак нэтижелер наукастардык опeрацияFа дeйiн McCormick модификацияланFан шкаласы бойынша жаксы кврceткiштeргe ие болуымен тiкeлeй байланысты. Уакыт аралы^ы хирургиянык кли-никалык нэтижeciнe айтарлыктай эсер eтпeдi. McCormick модификацияланFан шкаласы IMSCT бар наукастардык нэтижелерн жэне октайлы ре-зекциянык уакытын болжаудык макызды кврсет-кiшi болып табылады деп eceптeймiз.
Нег1зг[ свздер: интрамедуллярлы жулын iciгi, уакыт аралыFы, McCormick модификацияланFан шкаласы.
J.D. Banjarnahor1,2, R.H. Dahlan1,2,3, S.E. Ompusunggu
1,2,3
1 Общая больница им. Х. Садикин, г. Бандунг, Индонезия
2 Университет Паджаджаран, г. Бандунг, Индонезия
3 RFS Spine Care, г. Бандунг, Индонезия
ВЛИЯНИЕ ВРЕМЕННОГО ИНТЕРВАЛА НА КЛИНИЧЕСКИМ ИСХОД ОПЕРАЦИЙ БОЛЬНЫХ С ИНТРАМЕДУЛЯРНЫМИ ОПУХОЛЯМИ В ОБЩЕЙ
БОЛЬНИЦЕ ИМЕНИ ХАСАН САДИКИН
Цель: Авторы проанализировали результаты хирургии интрамедуллярных опухолей спинного мозга (IMSCT), сосредоточив внимание на доо-перационном и послеоперационном неврологическом статусе и влиянии временного интервала на клинический исход операции.
Методы: Проведен ретроспективный анализ медицинских карт 25 пациентов с интрамедулляр-ной опухолью, оперированных в период с января 2012 года по январь 2018 года. Оценивался пред-
и послеоперационный неврологический статус. Амбулаторный статус оценивался с использованием модифицированной шкалы Маккормика (MMS).
Результаты: 44% пациентов были в возрастной группе 41-60 лет (возрастной диапазон 18-80 лет; средний возраст 37 лет). Чаще всего поражался грудной отдел (48%). В предоперационном периоде по шкале Маккормика пациенты были распределены следующим образом; I у 0 (0%), II у 2 (8%), III у 6 (24%), IV у 10 (40%) и V у 7 (28%)
НЕЙРОХИРУРГИЯ И НЕВРОЛОГИЯ КАЗАХСТАНА
№1 (54) 2019
пациентов. Гистологически 60% поражений были эпендимомами. Общий послеоперационный неврологический статус улучшился у 8 (32%) пациентов, оставался неизменным в 27 (68%) случаях и ухудшился у 0 (0%) пациентов.
Заключение: Лучший результат прямо коррелировал с хорошей предоперационной модифицированной шкалой Маккормика. Временной интервал для операции существенно не влиял
на клинический исход. Мы полагаем, что Модифицированная Шкала Маккормика является значимым показателем при прогнозировании исхода и времени для оптимальной резекции у пациентов с IMSCT.
Ключевые слова: интрамедуллярная опухоль спинного мозга, временной интервал, модифицированная шкала Маккормика.
